Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by α2-adrenoceptors

This publication has 18 references indexed in Scilit:

• The Tyr-MIF-1 family of peptides
  Neuroscience & Biobehavioral Reviews, 1995
• Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine
  Peptides, 1994
• Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2)
  Peptides, 1994
• Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs
  Life Sciences, 1994
• Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)
  Peptides, 1992
• Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions
  Life Sciences, 1991
• Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (Tyr-MIF-1) as well as opiate binding sites in rat brain
  Life Sciences, 1989
• Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection of morphine into the periaqueductal gray
  Brain Research, 1985
• Spinal 5-HT or NA Uptake Inhibition Potentiates Supraspinal Morphine Antinociception in Rats
  Acta Pharmacologica et Toxicologica, 1984
• Endogenous opioid peptides: multiple agonists and receptors
  Nature, 1977